BNP PARIBAS FINANCIAL MARKETS - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 157 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$452,857
-36.7%
35,602
-30.0%
0.00%0.0%
Q2 2023$715,841
-68.6%
50,841
-65.5%
0.00%
-66.7%
Q1 2023$2,276,758
+38.0%
147,363
+46.4%
0.00%0.0%
Q4 2022$1,649,965
-99.9%
100,669
-40.3%
0.00%
-40.0%
Q3 2022$3,118,712,000
+278.3%
168,579
+168.9%
0.01%
+400.0%
Q2 2022$824,308,000
+277.5%
62,685
+166.1%
0.00%
Q1 2022$218,373,000
+11.0%
23,557
+17.0%
0.00%
Q4 2021$196,768,000
-62.8%
20,140
+29.5%
0.00%
-100.0%
Q3 2021$528,457,000
+62.8%
15,552
+75.4%
0.00%
Q2 2021$324,584,000
+6.3%
8,866
+30.2%
0.00%
Q1 2021$305,405,000
-90.7%
6,811
-88.1%
0.00%
-100.0%
Q4 2020$3,280,098,000
+502.8%
57,475
+441.9%
0.01%
+500.0%
Q3 2020$544,139,000
+93.7%
10,607
+125.4%
0.00%
Q2 2020$280,983,000
-46.5%
4,705
-63.1%
0.00%
-100.0%
Q1 2020$524,959,000
-76.4%
12,751
-64.3%
0.00%
-75.0%
Q4 2019$2,222,155,000
+2333.0%
35,703
+1226.8%
0.00%
Q3 2019$91,333,000
+311.6%
2,691
+173.5%
0.00%
Q2 2019$22,189,000
-47.9%
984
-46.3%
0.00%
Q1 2019$42,567,000
+67466.7%
1,834
+61033.3%
0.00%
Q4 2018$63,000
-99.4%
3
-98.9%
0.00%
Q3 2018$10,106,000
-17.7%
261
-16.3%
0.00%
Q2 2018$12,277,000
-55.6%
312
-77.4%
0.00%
Q1 2018$27,675,000
-25.8%
1,381
-16.0%
0.00%
Q4 2017$37,292,0001,6450.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$72,236,00020.73%
SV Health Investors, LLC 449,951$26,871,00018.64%
Redmile Group, LLC 4,978,941$297,342,0005.49%
Sunesis Advisors, LLC 96,299$5,751,0005.29%
Eversept Partners, LP 418,652$25,001,8973.43%
Opaleye Management Inc. 222,000$13,081,0002.64%
Avoro Capital Advisors LLC 1,860,000$111,079,0002.20%
SPHERA FUNDS MANAGEMENT LTD. 282,965$16,899,0001.59%
SECTORAL ASSET MANAGEMENT INC 224,359$13,399,0001.23%
Artal Group S.A. 650,000$38,818,0001.09%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders